NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients.
Pallarès V, Hoyos M, Chillón MC, Barragán E, Conde MIP, Llop M, Céspedes MV, Nomdedeu JF, Brunet S, Sanz MÁ, González-Díaz M, Sierra J, Casanova I, Mangues R.
Pallarès V, et al. Among authors: casanova i.
Oncotarget. 2017 Jun 16;8(44):76003-76014. doi: 10.18632/oncotarget.18537. eCollection 2017 Sep 29.
Oncotarget. 2017.
PMID: 29100287
Free PMC article.